Duranton Flore, Duny Yohan, Szwarc Ilan, Deleuze Sébastien, Rouanet Catherine, Selcer Isabelle, Maurice François, Rivory Jean-Pierre, Servel Marie-Françoise, Jover Bernard, Brunet Philippe, Daurès Jean-Pierre, Argilés Àngel
RD - Néphrologie/EA7288 , Université Montpellier , Montpellier, France.
EA2415 , Institut Universitaire de Recherche Clinique, Université Montpellier , Montpellier, France.
Clin Kidney J. 2016 Apr;9(2):287-94. doi: 10.1093/ckj/sfv153. Epub 2016 Jan 29.
While much research is devoted to identifying novel biomarkers, addressing the prognostic value of routinely measured clinical parameters is of great interest. We studied early blood pressure (BP) and body weight (BW) trajectories in incident haemodialysis patients and their association with all-cause mortality.
In a cohort of 357 incident patients, we obtained all records of BP and BW during the first 90 days on dialysis (over 12 800 observations) and analysed trajectories using penalized B-splines and mixed linear regression models. Baseline comorbidities and all-cause mortality (median follow-up: 2.2 years) were obtained from the French Renal Epidemiology and Information Network (REIN) registry, and the association with mortality was assessed by Cox models adjusting for baseline comorbidities.
During the initial 90 days on dialysis, there were non-linear decreases in BP and BW, with milder slopes after 15 days [systolic BP (SBP)] or 30 days [diastolic BP (DBP) and BW]. SBP or DBP levels at dialysis initiation and changes in BW occurring in the first month or during the following 2 months were significantly associated with survival. In multivariate models adjusting for baseline comorbidities and prescriptions, higher SBP value and BW slopes were independently associated with a lower risk of mortality. Hazard ratios of mortality and 95% confidence intervals were 0.92 (0.85-0.99) for a 10 mmHg higher SBP and 0.76 (0.66-0.88) for a 1 kg/month higher BW change on Days 30-90.
BW loss in the first weeks on dialysis is a strong and independent predictor of mortality. Low BP is also associated with mortality and is probably the consequence of underlying cardiovascular diseases. These early markers appear to be valuable prognostic factors.
尽管许多研究致力于寻找新的生物标志物,但探讨常规测量的临床参数的预后价值也备受关注。我们研究了新进入血液透析的患者早期的血压(BP)和体重(BW)轨迹及其与全因死亡率的关系。
在一个包含357例新进入患者的队列中,我们获取了透析开始后前90天内所有的血压和体重记录(超过12800次观察数据),并使用惩罚B样条和混合线性回归模型分析轨迹。从法国肾脏流行病学和信息网络(REIN)登记处获取基线合并症和全因死亡率(中位随访时间:2.2年),并通过对基线合并症进行调整的Cox模型评估其与死亡率的关联。
在透析开始后的最初90天内,血压和体重呈非线性下降,在15天[收缩压(SBP)]或30天[舒张压(DBP)和体重]后斜率变缓。透析开始时的SBP或DBP水平以及第一个月或接下来2个月内体重的变化与生存率显著相关。在对基线合并症和处方进行调整的多变量模型中,较高的SBP值和体重斜率与较低的死亡风险独立相关。在第30 - 90天,SBP每升高10 mmHg,死亡风险比和95%置信区间为0.92(0.85 - 0.99);体重变化每增加1 kg/月,死亡风险比和95%置信区间为0.76(0.66 - 0.88)。
透析开始后第一周内体重减轻是死亡率的一个强有力的独立预测因素。低血压也与死亡率相关,可能是潜在心血管疾病的结果。这些早期指标似乎是有价值的预后因素。